Cargando…

P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales: Yuan, Linyu, Xiaohui, Suo, Bai, Guanchen, LI, Hong, Han, Zhongjing, Zhang, Congcong, LI, Yinling, Gao, Sifeng, Zhang, Jilei, Lu, Xinxiao, Liu, Kaiqi, Xingli, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428780/
http://dx.doi.org/10.1097/01.HS9.0000968936.50207.1e
_version_ 1785090551649927168
author Yuan, Linyu
Xiaohui, Suo
Bai, Guanchen
LI, Hong
Han, Zhongjing
Zhang, Congcong
LI, Yinling
Gao, Sifeng
Zhang, Jilei
Lu, Xinxiao
Liu, Kaiqi
Xingli, Zhao
author_facet Yuan, Linyu
Xiaohui, Suo
Bai, Guanchen
LI, Hong
Han, Zhongjing
Zhang, Congcong
LI, Yinling
Gao, Sifeng
Zhang, Jilei
Lu, Xinxiao
Liu, Kaiqi
Xingli, Zhao
author_sort Yuan, Linyu
collection PubMed
description
format Online
Article
Text
id pubmed-10428780
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287802023-08-17 P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA Yuan, Linyu Xiaohui, Suo Bai, Guanchen LI, Hong Han, Zhongjing Zhang, Congcong LI, Yinling Gao, Sifeng Zhang, Jilei Lu, Xinxiao Liu, Kaiqi Xingli, Zhao Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428780/ http://dx.doi.org/10.1097/01.HS9.0000968936.50207.1e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Yuan, Linyu
Xiaohui, Suo
Bai, Guanchen
LI, Hong
Han, Zhongjing
Zhang, Congcong
LI, Yinling
Gao, Sifeng
Zhang, Jilei
Lu, Xinxiao
Liu, Kaiqi
Xingli, Zhao
P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title_full P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title_fullStr P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title_full_unstemmed P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title_short P507: SALVAGE THERAPY WITH VENETOCLAX IN COMBINATION WITH AZACITIDINE, HOMOHARRINGTONINE AND CYTARABINE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
title_sort p507: salvage therapy with venetoclax in combination with azacitidine, homoharringtonine and cytarabine in patients with relapsed/refractory acute myeloid leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428780/
http://dx.doi.org/10.1097/01.HS9.0000968936.50207.1e
work_keys_str_mv AT yuanlinyu p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT xiaohuisuo p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT baiguanchen p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT lihong p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT hanzhongjing p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT zhangcongcong p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT liyinling p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT gaosifeng p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT zhangjilei p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT luxinxiao p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT liukaiqi p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia
AT xinglizhao p507salvagetherapywithvenetoclaxincombinationwithazacitidinehomoharringtonineandcytarabineinpatientswithrelapsedrefractoryacutemyeloidleukemia